Hauser Aims to Spotlight Pharmacy Shortages and Rural Healthcare Gaps
Gerald Hauser’s parliamentary question seeks to expose the dwindling number of independent pharmacies across Europe and its consequences, particularly for rural communities. His inquiry puts the spotlight on healthcare providers, patients relying on local pharmacies, online medicine retailers, and EU health authorities. The issue stirs debate on the future of healthcare access at grassroots levels.
Response to Hauser’s Parliamentary Question
This answer responds to Hauser’s written question E-003369/2025 submitted on 2 September 2025, addressing the European Commission’s stance on pharmacy decline and online medicines trade amidst looming healthcare staffing shortages.
Concrete Proposals vs. General Policy:
The Commission’s response relies largely on existing frameworks and guidance rather than new concrete measures. It reiterates that health policy, including pharmacy regulation, rests with Member States. While acknowledging challenges, it references EU funding instruments like the Common Agricultural Policy (CAP) and European Regional Development Fund (ERDF) to support rural services and infrastructure. Enforcement against counterfeit online medicine imports is tied to OLAF’s ongoing work. No new numerical targets or budgets are introduced.
Policy Orientations:
The reply reflects a preference for national sovereignty over health system organization, endorsing EU support mainly through financial instruments and recommendation-driven initiatives. It balances protecting consumers from uncontrolled online medicine sales via Member States’ legal frameworks with encouraging integrated rural development to sustain pharmacy services without extending EU regulatory reach.
Stakeholder Impact:
For independent pharmacies facing competition and personnel shortages, the answer implies indirect support via CAP investments but leaves primary responsibility to Member States, which might limit immediate relief. EU consumers, especially in rural areas, could benefit from improved infrastructure and service access if regional funds are deployed effectively; however, risks from online medicine trade persist due to fragmented regulation. EU taxpayers fund these initiatives, potentially yielding long-term healthcare access benefits. Online retailers must comply with national law, and enforcement by OLAF may increase oversight costs.
Institutional Follow-up:
As a formal reply, the Commission’s answer signals its current stance to the Parliament within the standard response timeframe. It frames expected Member State-led actions supported by EU funds while highlighting enforcement roles without proposing new EU-level regulatory expansion.
← Atlas › News › Health & Lifestyle